Interventional Oncology Devices Market Size, Share, Trends, Growth Outlook

Interventional Oncology Devices Market is estimated to increase at a Compounded Annual Growth Rate of 7.5% CAGR over the forecast period from 2024 to 2030

The Interventional Oncology Devices Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments- By Product (Ablation Devices, Embolization Device, Microcatheters, Guidewires, Others), By Cancer (Lung cancer, Breast Cancer, Liver Cancer, Kidney Cancer, Prostate Cancer, Others).

An Introduction to Interventional Oncology Devices Market in 2024

In 2024, the market for interventional oncology devices continues to advance, offering minimally invasive treatment options for patients with cancer that complement traditional surgery, chemotherapy, and radiation therapy. Interventional oncology encompasses a broad range of image-guided procedures, including radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, transarterial chemoembolization (TACE), radioembolization, and percutaneous tumor biopsies. These techniques enable targeted destruction or modulation of tumors while minimizing damage to surrounding healthy tissues, resulting in fewer complications, shorter recovery times, and improved quality of life for patients. Technological innovations in interventional oncology devices, including next-generation ablation systems, advanced imaging modalities, and navigational tools, enhance procedural accuracy, safety, and efficacy, expanding the scope of minimally invasive cancer treatments available to patients. With the increasing incidence of cancer and the growing demand for personalized, multidisciplinary cancer care, the interventional oncology devices market is poised for continued growth and innovation, driving advancements in cancer treatment paradigms and patient outcomes.

Market Trend: Shift Towards Minimally Invasive Procedures

Interventional oncology devices are witnessing a prominent trend towards the shift from traditional surgical interventions to minimally invasive procedures. As advancements in medical technology and imaging techniques continue to evolve, there is increasing emphasis on minimally invasive approaches for the diagnosis and treatment of cancer. Interventional oncology procedures such as radiofrequency ablation (RFA), microwave ablation, cryoablation, and transarterial chemoembolization (TACE) offer less invasive alternatives to surgery, providing patients with faster recovery times, reduced post-operative complications, and improved quality of life. The trend towards minimally invasive procedures in oncology reflects a growing preference among patients and healthcare providers for treatments that offer effective disease management while minimizing the physical and emotional burdens associated with traditional surgery.

Market Driver: Growing Incidence of Cancer and Demand for Effective Treatment Options

A key driver for the interventional oncology devices market is the growing incidence of cancer and the corresponding demand for effective treatment options. Cancer remains a leading cause of morbidity and mortality worldwide, with millions of new cases diagnosed each year. As the prevalence of cancer continues to rise due to factors such as aging populations, lifestyle changes, and environmental factors, there is an urgent need for innovative and targeted therapies to combat the disease. Interventional oncology devices play a crucial role in delivering localized treatments directly to tumors, offering effective tumor control, symptom relief, and improved survival outcomes for cancer patients. The increasing demand for minimally invasive oncology treatments drives market growth for interventional oncology devices as healthcare providers seek to expand their treatment options and improve patient outcomes in the fight against cancer.

Market Opportunity: Development of Image-Guided Therapies and Combination Therapies

An emerging opportunity in the interventional oncology devices market lies in the development of image-guided therapies and combination therapies. Image-guided therapies, such as ablation techniques and targeted embolization procedures, rely on advanced imaging modalities such as computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound to precisely localize and treat tumors while minimizing damage to surrounding healthy tissue. By investing in the development of image-guided technologies and techniques, manufacturers can enhance the accuracy, safety, and efficacy of interventional oncology procedures, expanding the applicability of these therapies to a wider range of cancer types and patient populations. Additionally, there is potential for the development of combination therapies that combine interventional oncology devices with other treatment modalities such as chemotherapy, immunotherapy, or radiation therapy to synergistically target cancer cells and improve treatment outcomes. By exploring these opportunities, companies can differentiate their offerings, address unmet medical needs, and drive innovation in the field of interventional oncology.

Interventional Oncology Devices Market Share Analysis: Ablation Devices

In the Interventional Oncology Devices Market, the segment experiencing the fastest growth is Ablation Devices. Ablation devices are minimally invasive instruments used to destroy cancerous tumors through techniques such as radiofrequency ablation (RFA), microwave ablation (MWA), cryoablation, and irreversible electroporation (IRE). These devices offer a targeted approach to tumor destruction, allowing for precise treatment while minimizing damage to surrounding healthy tissues. Ablation procedures are commonly used in the treatment of various cancers, including liver cancer, lung cancer, kidney cancer, and prostate cancer, among others. With advancements in ablation technology, improved imaging modalities, and expanding indications for ablation procedures, there is a growing demand for ablation devices in interventional oncology. Additionally, as healthcare providers and patients increasingly seek minimally invasive alternatives to traditional surgery and radiation therapy, the market for ablation devices is poised for significant growth in the Interventional Oncology Devices Market.

Interventional Oncology Devices Competitive Analysis

The market research study provides in-depth insights into leading companies including the SWOT analyses, product profile, financial details, and recent developments acrossAngioDynamics Inc, Becton, Dickinson and Company, Boston Scientific Corp, Cook Group Inc, HealthTronics Inc, IceCure Medical Ltd, Medtronic plc, Merit Medical Systems Inc, Profound Medical Corp, Terumo Corp

Interventional Oncology Devices Market Segmentation

By Product
Ablation Devices
-Microwave ablation
-Radiofrequency ablation
-Cryoablation
-Others
Embolization Device
Microcatheters
Guidewires
Others
By Cancer
Lung cancer
Breast Cancer
Liver Cancer
Kidney Cancer
Prostate Cancer
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Interventional Oncology Devices Market Companies

AngioDynamics Inc
Becton, Dickinson and Company
Boston Scientific Corp
Cook Group Inc
HealthTronics Inc
IceCure Medical Ltd
Medtronic plc
Merit Medical Systems Inc
Profound Medical Corp
Terumo Corp

Reasons to Buy the Interventional Oncology Devices Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Interventional Oncology Devices Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Interventional Oncology Devices Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Interventional Oncology Devices Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Covered
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Interventional Oncology Devices Market Size Outlook, $ Million, 2021 to 2030
3.2 Interventional Oncology Devices Market Outlook by Type, $ Million, 2021 to 2030
3.3 Interventional Oncology Devices Market Outlook by Product, $ Million, 2021 to 2030
3.4 Interventional Oncology Devices Market Outlook by Application, $ Million, 2021 to 2030
3.5 Interventional Oncology Devices Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Interventional Oncology Devices Industry
4.2 Key Market Trends in Interventional Oncology Devices Industry
4.3 Potential Opportunities in Interventional Oncology Devices Industry
4.4 Key Challenges in Interventional Oncology Devices Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Interventional Oncology Devices Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Interventional Oncology Devices Market Outlook by Segments
7.1 Interventional Oncology Devices Market Outlook by Segments, $ Million, 2021- 2030
By Product
Ablation Devices
-Microwave ablation
-Radiofrequency ablation
-Cryoablation
-Others
Embolization Device
Microcatheters
Guidewires
Others
By Cancer
Lung cancer
Breast Cancer
Liver Cancer
Kidney Cancer
Prostate Cancer
Others

8 North America Interventional Oncology Devices Market Analysis and Outlook To 2030
8.1 Introduction to North America Interventional Oncology Devices Markets in 2024
8.2 North America Interventional Oncology Devices Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Interventional Oncology Devices Market size Outlook by Segments, 2021-2030
By Product
Ablation Devices
-Microwave ablation
-Radiofrequency ablation
-Cryoablation
-Others
Embolization Device
Microcatheters
Guidewires
Others
By Cancer
Lung cancer
Breast Cancer
Liver Cancer
Kidney Cancer
Prostate Cancer
Others

9 Europe Interventional Oncology Devices Market Analysis and Outlook To 2030
9.1 Introduction to Europe Interventional Oncology Devices Markets in 2024
9.2 Europe Interventional Oncology Devices Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Interventional Oncology Devices Market Size Outlook by Segments, 2021-2030
By Product
Ablation Devices
-Microwave ablation
-Radiofrequency ablation
-Cryoablation
-Others
Embolization Device
Microcatheters
Guidewires
Others
By Cancer
Lung cancer
Breast Cancer
Liver Cancer
Kidney Cancer
Prostate Cancer
Others

10 Asia Pacific Interventional Oncology Devices Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Interventional Oncology Devices Markets in 2024
10.2 Asia Pacific Interventional Oncology Devices Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Interventional Oncology Devices Market size Outlook by Segments, 2021-2030
By Product
Ablation Devices
-Microwave ablation
-Radiofrequency ablation
-Cryoablation
-Others
Embolization Device
Microcatheters
Guidewires
Others
By Cancer
Lung cancer
Breast Cancer
Liver Cancer
Kidney Cancer
Prostate Cancer
Others

11 South America Interventional Oncology Devices Market Analysis and Outlook To 2030
11.1 Introduction to South America Interventional Oncology Devices Markets in 2024
11.2 South America Interventional Oncology Devices Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Interventional Oncology Devices Market size Outlook by Segments, 2021-2030
By Product
Ablation Devices
-Microwave ablation
-Radiofrequency ablation
-Cryoablation
-Others
Embolization Device
Microcatheters
Guidewires
Others
By Cancer
Lung cancer
Breast Cancer
Liver Cancer
Kidney Cancer
Prostate Cancer
Others
12 Middle East and Africa Interventional Oncology Devices Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Interventional Oncology Devices Markets in 2024
12.2 Middle East and Africa Interventional Oncology Devices Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Interventional Oncology Devices Market size Outlook by Segments, 2021-2030
By Product
Ablation Devices
-Microwave ablation
-Radiofrequency ablation
-Cryoablation
-Others
Embolization Device
Microcatheters
Guidewires
Others
By Cancer
Lung cancer
Breast Cancer
Liver Cancer
Kidney Cancer
Prostate Cancer
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AngioDynamics Inc
Becton, Dickinson and Company
Boston Scientific Corp
Cook Group Inc
HealthTronics Inc
IceCure Medical Ltd
Medtronic plc
Merit Medical Systems Inc
Profound Medical Corp
Terumo Corp

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Ablation Devices
-Microwave ablation
-Radiofrequency ablation
-Cryoablation
-Others
Embolization Device
Microcatheters
Guidewires
Others
By Cancer
Lung cancer
Breast Cancer
Liver Cancer
Kidney Cancer
Prostate Cancer
Others
Countries Analyzed
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)